PhoPQ two-component regulatory system plays a global regulatory role in antibiotic susceptibility, physiology, stress adaptation, and virulence in Stenotrophomonas maltophilia.

Hsu-Feng Lu, Bo-Kuan Wu, Yi-Wei Huang, Ming-Zhe Lee, Ming-Fang Li, Hsu-Jung Ho, Hung-Chi Yang, Tsuey-Ching Yang
Author Information
  1. Hsu-Feng Lu: Department of Clinical Pathology, Cheng Hsin General Hospital, Taipei, Taiwan.
  2. Bo-Kuan Wu: Department of Biotechnology and Laboratory Science in Medicine, National Yang-Ming University, Taipei, Taiwan.
  3. Yi-Wei Huang: Department of Biotechnology and Laboratory Science in Medicine, National Yang-Ming University, Taipei, Taiwan.
  4. Ming-Zhe Lee: Department of Clinical Pathology, Cheng Hsin General Hospital, Taipei, Taiwan.
  5. Ming-Fang Li: Department of Medical Laboratory Science and Biotechnology, Yuanpei University of Medical Technology, Hsinchu, Taiwan.
  6. Hsu-Jung Ho: Department of Medical Laboratory Science and Biotechnology, Yuanpei University of Medical Technology, Hsinchu, Taiwan.
  7. Hung-Chi Yang: Department of Medical Laboratory Science and Biotechnology, Yuanpei University of Medical Technology, Hsinchu, Taiwan. hcyang@mail.ypu.edu.tw.
  8. Tsuey-Ching Yang: Department of Biotechnology and Laboratory Science in Medicine, National Yang-Ming University, Taipei, Taiwan. tcyang@ym.edu.tw.

Abstract

BACKGROUND: Stenotrophomonas maltophilia, an opportunistic pathogen, is ubiquitously present in various environments, signifying its high capability of environmental adaptation. Two-component regulatory system (TCS) is a powerful implement to help organisms to survive in different environments. In clinic, treatment of S. maltophilia infection is difficult because it is naturally resistant to many antibiotics, highlighting the necessity to develop novel drugs or adjuvants. Given their critical and extensively regulatory role, TCS system has been proposed as a convincing target for novel drugs or adjuvants. PhoPQ TCS, a highly conserved TCS in several pathogens, plays crucial roles in low-magnesium adaption, polymyxin resistance, and virulence. In this study, we aimed to characterize the role of PhoPQ TCS of S. maltophilia in antibiotic susceptibility, physiology, stress adaptation, and virulence.
RESULTS: To characterize PhoPQ system, phoP single mutant as well as phoP and phoQ double mutant were constructed. Distinct from most phoPQ systems of other microorganisms, two features were observed during the construction of phoP and phoQ single deletion mutant. Firstly, the phoQ mutant was not successfully obtained. Secondly, the compromised phenotypes of phoP mutant were not reverted by complementing an intact phoP gene, but were partially restored by complementing a phoPQ operon. Thus, wild-type KJ, phoP mutant (KJΔPhoP), phoPQ mutant (KJΔPhoPQ), and complemented strain (KJΔPhoPQ (pPhoPQ)) were used for functional assays, including antibiotic susceptibility, physiology (swimming motility and secreted protease activity), stress adaptation (oxidative, envelope, and iron-depletion stresses), and virulence to Caenorhabditis elegans. KJΔPhoPQ totally lost swimming motility, had enhanced secreted protease activity, increased susceptibility to antibiotics (β-lactam, quinolone, aminoglycoside, macrolide, chloramphenicol, and sulfamethoxazole/ trimethoprim), menadione, HO, SDS, and 2,2'-dipyridyl, as well as attenuated virulence to C. elegans. Trans-complementation of KJΔPhoPQ with phoPQ reverted these altered phenotypes to the wild-type levels.
CONCLUSIONS: Given the critical and global roles of PhoPQ TCS in antibiotic susceptibility, physiology, stress adaptation, and virulence, PhoPQ is a potential target for the design of drugs or adjuvants.

Keywords

References

  1. FEMS Microbiol Rev. 2009 Mar;33(2):279-94 [PMID: 19243444]
  2. Can J Microbiol. 2014 Dec;60(12):783-91 [PMID: 25388098]
  3. Mol Cell. 2007 Apr 27;26(2):165-74 [PMID: 17466620]
  4. Adv Exp Med Biol. 2008;631:7-21 [PMID: 18792679]
  5. PLoS One. 2016 May 09;11(5):e0153753 [PMID: 27159404]
  6. Antimicrob Agents Chemother. 2019 Mar 27;63(4): [PMID: 30745379]
  7. J Bacteriol. 1999 Sep;181(17):5516-20 [PMID: 10464230]
  8. J Antimicrob Chemother. 2014 Dec;69(12):3221-6 [PMID: 25139838]
  9. Cell. 1996 Jan 12;84(1):165-74 [PMID: 8548821]
  10. Methods. 2001 Dec;25(4):402-8 [PMID: 11846609]
  11. Nucleic Acids Res. 2007 Jan;35(Database issue):D472-5 [PMID: 17099225]
  12. Proc Natl Acad Sci U S A. 2017 Dec 12;114(50):E10792-E10798 [PMID: 29183977]
  13. Cell. 2005 Aug 12;122(3):461-72 [PMID: 16096064]
  14. J Biomed Sci. 2020 Feb 25;27(1):37 [PMID: 32093695]
  15. Antimicrob Agents Chemother. 2009 Jul;53(7):2902-7 [PMID: 19414581]
  16. J Neurosci Methods. 2019 Dec 1;328:108415 [PMID: 31470028]
  17. Genetics. 2017 Aug;206(4):2207-2223 [PMID: 28550013]
  18. Front Microbiol. 2015 Sep 02;6:893 [PMID: 26388847]
  19. Mol Microbiol. 1999 Oct;34(2):305-16 [PMID: 10564474]
  20. J Bacteriol. 2006 Jun;188(11):3995-4006 [PMID: 16707691]
  21. Subcell Biochem. 2013;66:161-92 [PMID: 23479441]
  22. Antimicrob Agents Chemother. 2018 Jan 25;62(2): [PMID: 29203487]
  23. BMC Genomics. 2008 Mar 27;9:143 [PMID: 18366809]
  24. J Antimicrob Chemother. 2020 Aug 1;75(8):2101-2109 [PMID: 32407477]
  25. Annu Rev Genet. 1991;25:315-37 [PMID: 1667460]
  26. Microbiology (Reading). 2009 Mar;155(Pt 3):699-711 [PMID: 19246741]
  27. Arch Biochem Biophys. 2012 Sep 15;525(2):145-60 [PMID: 22609271]
  28. J Gerontol. 1979 Jan;34(1):28-36 [PMID: 153363]
  29. Genome Biol. 2008 Apr 17;9(4):R74 [PMID: 18419807]
  30. Clin Microbiol Rev. 2012 Jan;25(1):2-41 [PMID: 22232370]
  31. J Bacteriol. 2001 Mar;183(6):1835-42 [PMID: 11222580]
  32. Int J Mol Sci. 2019 Apr 10;20(7): [PMID: 30974814]
  33. Antimicrob Agents Chemother. 2015 Jul;59(7):4067-73 [PMID: 25918140]
  34. Future Microbiol. 2014;9(11):1283-93 [PMID: 25437189]
  35. Antimicrob Agents Chemother. 2016 Apr 22;60(5):3016-24 [PMID: 26953208]
  36. Microbiol Res. 2009;164(1):18-26 [PMID: 18395434]

Grants

  1. MOST108-2320-B-010-032-MY3/Ministry of Science and Technology, Taiwan
  2. MOST108-2320-B-264-002/Ministry of Science and Technology, Taiwan
  3. CHGH109-37/Cheng Hsin General Hospital Foundation
  4. CY10928/Cheng Hsin General Hospital Foundation
  5. 30719003/Professor Tsuei-Chu Mong Merit Scholarship

MeSH Term

Anti-Bacterial Agents
Bacterial Proteins
Microbial Sensitivity Tests
Stenotrophomonas maltophilia
Virulence
beta-Lactam Resistance
beta-Lactamases

Chemicals

Anti-Bacterial Agents
Bacterial Proteins
beta-Lactamases